Kiora Pharmaceuticals (KPRX) Goodwill & Intangibles (2016 - 2026)

Kiora Pharmaceuticals (KPRX) has 11 years of Goodwill & Intangibles data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 69.15% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 69.15% YoY) and the FY2025 annual result came in at $2.1 million, down 69.15% from the prior year.
• Goodwill & Intangibles held at $2.1 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $10.8 million in Q1 2022 to a low of $2.1 million in Q4 2025.
• A 5-year average of $8.1 million and a median of $8.8 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles gained 9.04% — and 2025, when it plunged 69.15%.
• Tracing KPRX's Goodwill & Intangibles over 5 years: stood at $10.7 million in 2022, then dropped by 17.96% to $8.8 million in 2023, then declined by 24.13% to $6.7 million in 2024, then sank by 69.15% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
• The last three Goodwill & Intangibles figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.